Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sudhesh Kumar

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Expert Review of Endocrinology & Metabolism|February 13, 2019
Cardiometabolic risk factors and their treatment in patients with Type 2 diabetesSudhesh Kumar
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|July 15, 2010
Obesity and diabetesKonstantinos Lois, Sudhesh Kumar
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|June 15, 2010
Obesity and diabetesKonstantinos Lois, Sudhesh Kumar
The Journal of Clinical Endocrinology and Metabolism|July 10, 2007
Editorial: Retinol binding protein 4 and pathogenesis of diabetesPhilip G McTernan, Sudhesh Kumar
Expert Opinion on Pharmacotherapy|December 11, 2002
Pharmacological management of obesityM Wasim Hanif, Sudhesh Kumar
Best Practice & Research. Clinical Endocrinology & Metabolism|December 7, 2007
Potential therapies based on antidiabetic peptidesTom Billyard, Philip McTernan, Sudhesh Kumar
Current Opinion in Lipidology|March 15, 2006
ResistinPhilip G McTernan, Christine M Kusminski, Sudhesh Kumar
The Journal of Clinical Endocrinology and Metabolism|November 4, 2004
Essential role of fibroblast growth factor signaling in preadipoctye differentiationNayan G Patel, Sudhesh Kumar, Margaret C Eggo
Clinical Science (London, England : 1979)|August 18, 2005
Role of resistin in obesity, insulin resistance and Type II diabetesChristine M Kusminski, Philip G McTernan, Sudhesh Kumar
Hormones (Athens, Greece)|October 15, 2013
Metabolic and other effects of pioglitazone as an add-on therapy to metformin in the treatment of polycystic ovary syndrome (PCOS)Georgios Valsamakis, Kostas Lois, Sudhesh Kumar, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Expert Review of Endocrinology & Metabolism|February 13, 2019
Cardiometabolic risk factors and their treatment in patients with Type 2 diabetesSudhesh Kumar
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|July 15, 2010
Obesity and diabetesKonstantinos Lois, Sudhesh Kumar
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|June 15, 2010
Obesity and diabetesKonstantinos Lois, Sudhesh Kumar
The Journal of Clinical Endocrinology and Metabolism|July 10, 2007
Editorial: Retinol binding protein 4 and pathogenesis of diabetesPhilip G McTernan, Sudhesh Kumar
Expert Opinion on Pharmacotherapy|December 11, 2002
Pharmacological management of obesityM Wasim Hanif, Sudhesh Kumar
Best Practice & Research. Clinical Endocrinology & Metabolism|December 7, 2007
Potential therapies based on antidiabetic peptidesTom Billyard, Philip McTernan, Sudhesh Kumar
Current Opinion in Lipidology|March 15, 2006
ResistinPhilip G McTernan, Christine M Kusminski, Sudhesh Kumar
The Journal of Clinical Endocrinology and Metabolism|November 4, 2004
Essential role of fibroblast growth factor signaling in preadipoctye differentiationNayan G Patel, Sudhesh Kumar, Margaret C Eggo
Clinical Science (London, England : 1979)|August 18, 2005
Role of resistin in obesity, insulin resistance and Type II diabetesChristine M Kusminski, Philip G McTernan, Sudhesh Kumar
Hormones (Athens, Greece)|October 15, 2013
Metabolic and other effects of pioglitazone as an add-on therapy to metformin in the treatment of polycystic ovary syndrome (PCOS)Georgios Valsamakis, Kostas Lois, Sudhesh Kumar, et al.
Pageof 10